GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2021-10-07| In-Depth

Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation

by Rajaneesh K. Gopinath
Share To
As opposed to large molecule biologics such as monoclonal antibodies, vaccines, or other proteins, small molecule drugs offer several advantages. Their small size, low immunogenicity, easy permeability, and most importantly, a simple and stable structure allow them to hit a therapeutic target better. Also, they are easily convertible to the oral form, and they are very cost-effective.

The biopharma industry spends millions on small molecule drug discovery, and forecasters estimate that the market will reach $50,823.06 million in value by 2027. However, the process of bringing small molecule drugs to the clinic is long, even though their manufacturing is relatively simple.

In addition to the technical challenges, often, only one out of every 10,000 compounds go on to obtain regulatory approval. Therefore, as opposed to the conventional drugs that block protein activity, the industry is now pursuing a new type of small molecule known as “Targeted protein degraders”. This exciting technology has become a hot commodity for drug discovery, giving way to large deal-making between companies and the launch of new startups that are racking in the big bucks.

GO Prime with only $1.49 now

LATEST
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation
2025-02-11
Trump’s Trade War Shake-Up: How U.S. Tariffs Could Disrupt Global Pharma
2025-02-10
Precision Medicine Market Skyrocketing, Shaking the Industry with $470.53 Billion Expected by 2034
2025-02-10
Super Bowl LIX and the Biotech Sector: A New Arena for Engagement
2025-02-09
What the PlayStation Network Outage Can Teach the Biotech Industry
2025-02-08
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top